/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,.
VANCOUVER, British Columbia, April 25, 2022 Filament Health , a clinical-stage natural psychedelic drug development company, today announced that Benjamin Lightburn, CEO and Co-Founder,. | April 25, 2022